Session 2: Updates in Chronic Liver Disease
| Saturday, September 12, 2026 |
Overview
Moderator – Dr. Erin Kelly
Details
Learning Objectives:
• Outline novel therapeutic treatment options in PSC, MASLD and Hepatitis delta
• Discuss updated treatment guidelines in managing patients with Hepatitis B
• Discuss pathophysiology and impact of frailty and sarcopenia in patients with advanced liver disease